1[1]DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dys lipidemia, and atherosclerotic cardiovascular disease[J]. Diabetes Care, 1991,14(3): 173-194
2[2]Peiris AN, Mulier RA, Smith GA. Splanchinic insulin metabolism in obesity, influence of body fat distribution[J]. J Clin Invest, 1986, 78(6) :648-657
3[3]Zamboni M, Armellini F, Cominacini L, et al. Obesity and region al bocdy- fat distribution in men: separate and joint relationships to glucose tolerance and plasma lipoproteins[J]. Am J Clin Nutr, 1994, 60(5) :682-687
4[4]Peiris AN, Struve MF, Mueller RA, et al. Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution [J]. J Clin Endocrinol Metab, 1988, 67(4 ): 760-767
5[5]Steppan CM, Lazar MA. Resistin and obesity- associated insulin resistance[J]. Trends Endocrinol Metab, 2002, 13(1) :18-23
